SpringWorks Therapeutics Inc (SWTX)
44.19
+0.81
(+1.87%)
USD |
NASDAQ |
Apr 25, 16:00
44.19
0.00 (0.00%)
After-Hours: 20:00
SpringWorks Therapeutics Price to Book Value: 5.207 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 5.111 |
| April 23, 2024 | 5.184 |
| April 22, 2024 | 5.054 |
| April 19, 2024 | 4.725 |
| April 18, 2024 | 5.004 |
| April 17, 2024 | 5.197 |
| April 16, 2024 | 5.114 |
| April 15, 2024 | 5.009 |
| April 12, 2024 | 5.037 |
| April 11, 2024 | 5.197 |
| April 10, 2024 | 5.134 |
| April 09, 2024 | 5.210 |
| April 08, 2024 | 5.192 |
| April 05, 2024 | 5.242 |
| April 04, 2024 | 5.246 |
| April 03, 2024 | 5.446 |
| April 02, 2024 | 5.454 |
| April 01, 2024 | 5.611 |
| March 28, 2024 | 5.800 |
| March 27, 2024 | 5.903 |
| March 26, 2024 | 5.797 |
| March 25, 2024 | 5.824 |
| March 22, 2024 | 5.984 |
| March 21, 2024 | 6.064 |
| March 20, 2024 | 5.921 |
| Date | Value |
|---|---|
| March 19, 2024 | 5.737 |
| March 18, 2024 | 5.706 |
| March 15, 2024 | 5.924 |
| March 14, 2024 | 5.830 |
| March 13, 2024 | 6.039 |
| March 12, 2024 | 5.862 |
| March 11, 2024 | 5.708 |
| March 08, 2024 | 6.018 |
| March 07, 2024 | 6.186 |
| March 06, 2024 | 6.177 |
| March 05, 2024 | 5.932 |
| March 04, 2024 | 5.862 |
| March 01, 2024 | 6.010 |
| February 29, 2024 | 5.804 |
| February 28, 2024 | 5.728 |
| February 27, 2024 | 6.135 |
| February 26, 2024 | 5.712 |
| February 23, 2024 | 5.788 |
| February 22, 2024 | 5.787 |
| February 21, 2024 | 5.800 |
| February 20, 2024 | 5.729 |
| February 16, 2024 | 6.147 |
| February 15, 2024 | 5.636 |
| February 14, 2024 | 5.460 |
| February 13, 2024 | 5.246 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.217
Minimum
Dec 19 2022
13.93
Maximum
Dec 22 2020
5.396
Average
5.194
Median
Price to Book Value Benchmarks
| Syndax Pharmaceuticals Inc | 3.156 |
| Alnylam Pharmaceuticals Inc | -- |
| Geron Corp | 7.862 |
| Ionis Pharmaceuticals Inc | 15.76 |
| Madrigal Pharmaceuticals Inc | 9.541 |
Price to Book Value Related Metrics
| Price | 44.19 |
| Earnings Yield | -11.65% |
| Market Cap | 3.261B |